Newsletter Signup | Join Community
Study reports that ~ 60% of patients with advanced bladder cancer respond to Votrient/Taxol chemotherapy
Doctors from MD Anderson report results of Balversa in advanced Urothelial cancer - Now FDA Approved
U.S. FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer
Intravesical Taxotere® Effective in Recurrent Superficial Bladder Cancer
Study from Sloan Kettering: Robot-assisted laparoscopic cystectomy takes longer to complete but has less blood loss
Taxotere® and Gemzar® is Effective for Treatment of Advanced Bladder Cancer
More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer
Information on Recurrent Bladder Cancer
Cancer Connect - Stage IV Bladder Cancer
Some individuals are more genetically susceptible to this risk.
Can anyone share the experience with Keytruda? Any side effects?